Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Influenza Drugs and Vaccines market report explains the definition, types, applications, major countries, and major players of the Influenza Drugs and Vaccines market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.
The report contains qualitative and quantitative analysis of the entire industry.
The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.
By Player:
BioCryst PharmaceuticalsInc
Emergent Biosolutions
Protein Sciences Corporation
Alvogen
Sanofi Pasteur Inc
Astrazeneca
Serum Institute Of India Pvt Ltd
Serum Institute Of India Pvt Ltd
Emergent Biosolutions
CSL Limited
ABPI
By Type:
Zanamivir
Oseltamivir Phosphate
Peramivir
Trivalent
Quadrivalent
By End-User:
Hospitals
Research Laboratories
Pharmacies
Others
By Region:
North America
-
United States
-
Canada
-
Mexico
Europe
-
Germany
-
UK
-
Spain
-
France
-
Italy
-
Denmark
-
Finland
-
Norway
-
Sweden
-
Poland
-
Russia
-
Turkey
Asia-Pacific
-
China
-
Japan
-
India
-
South Korea
-
Pakistan
-
Bangladesh
-
Indonesia
-
Thailand
-
Singapore
-
Malaysia
-
Philippines
-
Vietnam
-
Others
South America
-
Brazil
-
Colombia
-
Chile
-
Argentina
-
Venezuela
-
Peru
-
Puerto Rico
-
Ecuador
-
Others
GCC
-
Bahrain
-
Kuwait
-
Oman
-
Qatar
-
Saudi Arabia
-
United Arab Emirates
Africa
-
Nigeria
-
South Africa
-
Egypt
-
Algeriat
-
Others
Oceania
-
Australia
-
New Zealand
TABLE OF CONTENT
1. Global Influenza Drugs and Vaccines Executive Summary
-
1.1 Introduction
-
1.2 Market Panorama, 2022
2 Coronavirus Impact
-
2.1 Influenza Drugs and Vaccines Outlook to 2028- Original Forecasts
-
2.2 Influenza Drugs and Vaccines Outlook to 2028- COVID-19 Affected Forecasts
-
2.3 Impact on Industry
3 Strategic Analytics to Boost Productivity and Profitability
-
3.1 Potential Market Drivers and Opportunities
-
3.2 New Challenges and Strategies
-
3.3 Short Term and Long Term Influenza Drugs and Vaccines Market Trends
4 Key Inferences
5 Market Overview
-
5.1 Current Market Scenario
-
5.2 Porter's Five Forces Analysis
-
5.2.1 Bargaining Power of Suppliers
-
5.2.2 Bargaining Power of Consumers
-
5.2.3 Threat of New Entrants
-
5.2.4 Threat of Substitute Product and Services
-
5.2.5 Competitive Rivalry within the Industry
6 Global Influenza Drugs and Vaccines Market- Recent Developments
-
6.1 Influenza Drugs and Vaccines Market News and Developments
-
6.2 Influenza Drugs and Vaccines Market Deals Landscape
7 Influenza Drugs and Vaccines Raw Materials and Cost Structure Analysis
-
7.1 Influenza Drugs and Vaccines Key Raw Materials
-
7.2 Influenza Drugs and Vaccines Price Trend of Key Raw Materials
-
7.3 Influenza Drugs and Vaccines Key Suppliers of Raw Materials
-
7.4 Influenza Drugs and Vaccines Market Concentration Rate of Raw Materials
-
7.5 Influenza Drugs and Vaccines Cost Structure Analysis
-
7.5.1 Influenza Drugs and Vaccines Raw Materials Analysis
-
7.5.2 Influenza Drugs and Vaccines Labor Cost Analysis
-
7.5.3 Influenza Drugs and Vaccines Manufacturing Expenses Analysis
8 Global Influenza Drugs and Vaccines Import and Export Analysis (Top 10 Countries)
-
8.1 Global Influenza Drugs and Vaccines Import by Region (Top 10 Countries) (2017-2028)
-
8.2 Global Influenza Drugs and Vaccines Export by Region (Top 10 Countries) (2017-2028)
9 Global Influenza Drugs and Vaccines Market Outlook by Types and Applications to 2022
-
9.1 Global Influenza Drugs and Vaccines Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Zanamivir Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Oseltamivir Phosphate Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Peramivir Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Trivalent Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Quadrivalent Consumption and Growth Rate (2017-2022)
-
9.2 Global Influenza Drugs and Vaccines Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Research Laboratories Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Pharmacies Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Others Consumption and Growth Rate (2017-2022)
10 Region and Country-wise Influenza Drugs and Vaccines Market Analysis and Outlook till 2022
-
10.1 Global Influenza Drugs and Vaccines Consumption (2017-2022)
-
10.2 North America Consumption Analysis
-
10.2.1 United States Influenza Drugs and Vaccines Consumption (2017-2022)
-
10.2.2 Canada Influenza Drugs and Vaccines Consumption (2017-2022)
-
10.2.3 Mexico Influenza Drugs and Vaccines Consumption (2017-2022)
-
10.3 Europe Consumption Analysis
-
10.3.1 Germany Influenza Drugs and Vaccines Consumption (2017-2022)
-
10.3.2 UK Influenza Drugs and Vaccines Consumption (2017-2022)
-
10.3.3 Spain Influenza Drugs and Vaccines Consumption (2017-2022)
-
10.3.4 Belgium Influenza Drugs and Vaccines Consumption (2017-2022)
-
10.3.5 France Influenza Drugs and Vaccines Consumption (2017-2022)
-
10.3.6 Italy Influenza Drugs and Vaccines Consumption (2017-2022)
-
10.3.7 Denmark Influenza Drugs and Vaccines Consumption (2017-2022)
-
10.3.8 Finland Influenza Drugs and Vaccines Consumption (2017-2022)
-
10.3.9 Norway Influenza Drugs and Vaccines Consumption (2017-2022)
-
10.3.10 Sweden Influenza Drugs and Vaccines Consumption (2017-2022)
-
10.3.11 Poland Influenza Drugs and Vaccines Consumption (2017-2022)
-
10.3.12 Russia Influenza Drugs and Vaccines Consumption (2017-2022)
-
10.3.13 Turkey Influenza Drugs and Vaccines Consumption (2017-2022)
-
10.4 APAC Consumption Analysis
-
10.4.1 China Influenza Drugs and Vaccines Consumption (2017-2022)
-
10.4.2 Japan Influenza Drugs and Vaccines Consumption (2017-2022)
-
10.4.3 India Influenza Drugs and Vaccines Consumption (2017-2022)
-
10.4.4 South Korea Influenza Drugs and Vaccines Consumption (2017-2022)
-
10.4.5 Pakistan Influenza Drugs and Vaccines Consumption (2017-2022)
-
10.4.6 Bangladesh Influenza Drugs and Vaccines Consumption (2017-2022)
-
10.4.7 Indonesia Influenza Drugs and Vaccines Consumption (2017-2022)
-
10.4.8 Thailand Influenza Drugs and Vaccines Consumption (2017-2022)
-
10.4.9 Singapore Influenza Drugs and Vaccines Consumption (2017-2022)
-
10.4.10 Malaysia Influenza Drugs and Vaccines Consumption (2017-2022)
-
10.4.11 Philippines Influenza Drugs and Vaccines Consumption (2017-2022)
-
10.4.12 Vietnam Influenza Drugs and Vaccines Consumption (2017-2022)
-
10.5 South America Consumption Analysis
-
10.5.1 Brazil Influenza Drugs and Vaccines Consumption (2017-2022)
-
10.5.2 Colombia Influenza Drugs and Vaccines Consumption (2017-2022)
-
10.5.3 Chile Influenza Drugs and Vaccines Consumption (2017-2022)
-
10.5.4 Argentina Influenza Drugs and Vaccines Consumption (2017-2022)
-
10.5.5 Venezuela Influenza Drugs and Vaccines Consumption (2017-2022)
-
10.5.6 Peru Influenza Drugs and Vaccines Consumption (2017-2022)
-
10.5.7 Puerto Rico Influenza Drugs and Vaccines Consumption (2017-2022)
-
10.5.8 Ecuador Influenza Drugs and Vaccines Consumption (2017-2022)
-
10.6 GCC Consumption Analysis
-
10.6.1 Bahrain Influenza Drugs and Vaccines Consumption (2017-2022)
-
10.6.2 Kuwait Influenza Drugs and Vaccines Consumption (2017-2022)
-
10.6.3 Oman Influenza Drugs and Vaccines Consumption (2017-2022)
-
10.6.4 Qatar Influenza Drugs and Vaccines Consumption (2017-2022)
-
10.6.5 Saudi Arabia Influenza Drugs and Vaccines Consumption (2017-2022)
-
10.6.6 United Arab Emirates Influenza Drugs and Vaccines Consumption (2017-2022)
-
10.7 Africa Consumption Analysis
-
10.7.1 Nigeria Influenza Drugs and Vaccines Consumption (2017-2022)
-
10.7.2 South Africa Influenza Drugs and Vaccines Consumption (2017-2022)
-
10.7.3 Egypt Influenza Drugs and Vaccines Consumption (2017-2022)
-
10.7.4 Algeria Influenza Drugs and Vaccines Consumption (2017-2022)
-
10.8 Oceania Consumption Analysis
-
10.8.1 Australia Influenza Drugs and Vaccines Consumption (2017-2022)
-
10.8.2 New Zealand Influenza Drugs and Vaccines Consumption (2017-2022)
11 Global Influenza Drugs and Vaccines Competitive Analysis
-
11.1 BioCryst PharmaceuticalsInc
-
11.1.1 BioCryst PharmaceuticalsInc Company Details
-
11.1.2 BioCryst PharmaceuticalsInc Influenza Drugs and Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
11.1.3 BioCryst PharmaceuticalsInc Influenza Drugs and Vaccines Main Business and Markets Served
-
11.1.4 BioCryst PharmaceuticalsInc Influenza Drugs and Vaccines Product Portfolio
-
11.1.5 Recent Research and Development Strategies
-
11.2 Emergent Biosolutions
-
11.2.1 Emergent Biosolutions Company Details
-
11.2.2 Emergent Biosolutions Influenza Drugs and Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
11.2.3 Emergent Biosolutions Influenza Drugs and Vaccines Main Business and Markets Served
-
11.2.4 Emergent Biosolutions Influenza Drugs and Vaccines Product Portfolio
-
11.2.5 Recent Research and Development Strategies
-
11.3 Protein Sciences Corporation
-
11.3.1 Protein Sciences Corporation Company Details
-
11.3.2 Protein Sciences Corporation Influenza Drugs and Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
11.3.3 Protein Sciences Corporation Influenza Drugs and Vaccines Main Business and Markets Served
-
11.3.4 Protein Sciences Corporation Influenza Drugs and Vaccines Product Portfolio
-
11.3.5 Recent Research and Development Strategies
-
11.4 Alvogen
-
11.4.1 Alvogen Company Details
-
11.4.2 Alvogen Influenza Drugs and Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
11.4.3 Alvogen Influenza Drugs and Vaccines Main Business and Markets Served
-
11.4.4 Alvogen Influenza Drugs and Vaccines Product Portfolio
-
11.4.5 Recent Research and Development Strategies
-
11.5 Sanofi Pasteur Inc
-
11.5.1 Sanofi Pasteur Inc Company Details
-
11.5.2 Sanofi Pasteur Inc Influenza Drugs and Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
11.5.3 Sanofi Pasteur Inc Influenza Drugs and Vaccines Main Business and Markets Served
-
11.5.4 Sanofi Pasteur Inc Influenza Drugs and Vaccines Product Portfolio
-
11.5.5 Recent Research and Development Strategies
-
11.6 Astrazeneca
-
11.6.1 Astrazeneca Company Details
-
11.6.2 Astrazeneca Influenza Drugs and Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
11.6.3 Astrazeneca Influenza Drugs and Vaccines Main Business and Markets Served
-
11.6.4 Astrazeneca Influenza Drugs and Vaccines Product Portfolio
-
11.6.5 Recent Research and Development Strategies
-
11.7 Serum Institute Of India Pvt Ltd
-
11.7.1 Serum Institute Of India Pvt Ltd Company Details
-
11.7.2 Serum Institute Of India Pvt Ltd Influenza Drugs and Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
11.7.3 Serum Institute Of India Pvt Ltd Influenza Drugs and Vaccines Main Business and Markets Served
-
11.7.4 Serum Institute Of India Pvt Ltd Influenza Drugs and Vaccines Product Portfolio
-
11.7.5 Recent Research and Development Strategies
-
11.8 Serum Institute Of India Pvt Ltd
-
11.8.1 Serum Institute Of India Pvt Ltd Company Details
-
11.8.2 Serum Institute Of India Pvt Ltd Influenza Drugs and Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
11.8.3 Serum Institute Of India Pvt Ltd Influenza Drugs and Vaccines Main Business and Markets Served
-
11.8.4 Serum Institute Of India Pvt Ltd Influenza Drugs and Vaccines Product Portfolio
-
11.8.5 Recent Research and Development Strategies
-
11.9 Emergent Biosolutions
-
11.9.1 Emergent Biosolutions Company Details
-
11.9.2 Emergent Biosolutions Influenza Drugs and Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
11.9.3 Emergent Biosolutions Influenza Drugs and Vaccines Main Business and Markets Served
-
11.9.4 Emergent Biosolutions Influenza Drugs and Vaccines Product Portfolio
-
11.9.5 Recent Research and Development Strategies
-
11.10 CSL Limited
-
11.10.1 CSL Limited Company Details
-
11.10.2 CSL Limited Influenza Drugs and Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
11.10.3 CSL Limited Influenza Drugs and Vaccines Main Business and Markets Served
-
11.10.4 CSL Limited Influenza Drugs and Vaccines Product Portfolio
-
11.10.5 Recent Research and Development Strategies
-
11.11 ABPI
-
11.11.1 ABPI Company Details
-
11.11.2 ABPI Influenza Drugs and Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
11.11.3 ABPI Influenza Drugs and Vaccines Main Business and Markets Served
-
11.11.4 ABPI Influenza Drugs and Vaccines Product Portfolio
-
11.11.5 Recent Research and Development Strategies
12 Global Influenza Drugs and Vaccines Market Outlook by Types and Applications to 2028
-
12.1 Global Influenza Drugs and Vaccines Consumption Forecast and Growth Rate by Type (2022-2028)
-
12.1.1 Global Zanamivir Consumption Forecast and Growth Rate (2022-2028)
-
12.1.2 Global Oseltamivir Phosphate Consumption Forecast and Growth Rate (2022-2028)
-
12.1.3 Global Peramivir Consumption Forecast and Growth Rate (2022-2028)
-
12.1.4 Global Trivalent Consumption Forecast and Growth Rate (2022-2028)
-
12.1.5 Global Quadrivalent Consumption Forecast and Growth Rate (2022-2028)
-
12.2 Global Influenza Drugs and Vaccines Consumption Forecast and Growth Rate by Application (2022-2028)
-
12.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
12.2.2 Global Research Laboratories Consumption Forecast and Growth Rate (2022-2028)
-
12.2.3 Global Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
12.2.4 Global Others Consumption Forecast and Growth Rate (2022-2028)
13 Country-wise Influenza Drugs and Vaccines Market Analysis and Outlook to 2028
-
13.1 Global Influenza Drugs and Vaccines Consumption Forecast (2022-2028)
-
13.2 North America Consumption Analysis
-
13.2.1 United States Influenza Drugs and Vaccines Consumption Forecast (2022-2028)
-
13.2.2 Canada Influenza Drugs and Vaccines Consumption Forecast (2022-2028)
-
13.2.3 Mexico Influenza Drugs and Vaccines Consumption Forecast (2022-2028)
-
13.3 Europe Consumption Analysis
-
13.3.1 Germany Influenza Drugs and Vaccines Consumption Forecast (2022-2028)
-
13.3.2 UK Influenza Drugs and Vaccines Consumption Forecast (2022-2028)
-
13.3.3 Spain Influenza Drugs and Vaccines Consumption Forecast (2022-2028)
-
13.3.4 Belgium Influenza Drugs and Vaccines Consumption Forecast (2022-2028)
-
13.3.5 France Influenza Drugs and Vaccines Consumption Forecast (2022-2028)
-
13.3.6 Italy Influenza Drugs and Vaccines Consumption Forecast (2022-2028)
-
13.3.7 Denmark Influenza Drugs and Vaccines Consumption Forecast (2022-2028)
-
13.3.8 Finland Influenza Drugs and Vaccines Consumption Forecast (2022-2028)
-
13.3.9 Norway Influenza Drugs and Vaccines Consumption Forecast (2022-2028)
-
13.3.10 Sweden Influenza Drugs and Vaccines Consumption Forecast (2022-2028)
-
13.3.11 Poland Influenza Drugs and Vaccines Consumption Forecast (2022-2028)
-
13.3.12 Russia Influenza Drugs and Vaccines Consumption Forecast (2022-2028)
-
13.3.13 Turkey Influenza Drugs and Vaccines Consumption Forecast (2022-2028)
-
13.4 APAC Consumption Analysis
-
13.4.1 China Influenza Drugs and Vaccines Consumption Forecast (2022-2028)
-
13.4.2 Japan Influenza Drugs and Vaccines Consumption Forecast (2022-2028)
-
13.4.3 India Influenza Drugs and Vaccines Consumption Forecast (2022-2028)
-
13.4.4 South Korea Influenza Drugs and Vaccines Consumption Forecast (2022-2028)
-
13.4.5 Pakistan Influenza Drugs and Vaccines Consumption Forecast (2022-2028)
-
13.4.6 Bangladesh Influenza Drugs and Vaccines Consumption Forecast (2022-2028)
-
13.4.7 Indonesia Influenza Drugs and Vaccines Consumption Forecast (2022-2028)
-
13.4.8 Thailand Influenza Drugs and Vaccines Consumption Forecast (2022-2028)
-
13.4.9 Singapore Influenza Drugs and Vaccines Consumption Forecast (2022-2028)
-
13.4.10 Malaysia Influenza Drugs and Vaccines Consumption Forecast (2022-2028)
-
13.4.11 Philippines Influenza Drugs and Vaccines Consumption Forecast (2022-2028)
-
13.4.12 Vietnam Influenza Drugs and Vaccines Consumption Forecast (2022-2028)
-
13.5 South America Consumption Analysis
-
13.5.1 Brazil Influenza Drugs and Vaccines Consumption Forecast (2022-2028)
-
13.5.2 Colombia Influenza Drugs and Vaccines Consumption Forecast (2022-2028)
-
13.5.3 Chile Influenza Drugs and Vaccines Consumption Forecast (2022-2028)
-
13.5.4 Argentina Influenza Drugs and Vaccines Consumption Forecast (2022-2028)
-
13.5.5 Venezuela Influenza Drugs and Vaccines Consumption Forecast (2022-2028)
-
13.5.6 Peru Influenza Drugs and Vaccines Consumption Forecast (2022-2028)
-
13.5.7 Puerto Rico Influenza Drugs and Vaccines Consumption Forecast (2022-2028)
-
13.5.8 Ecuador Influenza Drugs and Vaccines Consumption Forecast (2022-2028)
-
13.6 GCC Consumption Analysis
-
13.6.1 Bahrain Influenza Drugs and Vaccines Consumption Forecast (2022-2028)
-
13.6.2 Kuwait Influenza Drugs and Vaccines Consumption Forecast (2022-2028)
-
13.6.3 Oman Influenza Drugs and Vaccines Consumption Forecast (2022-2028)
-
13.6.4 Qatar Influenza Drugs and Vaccines Consumption Forecast (2022-2028)
-
13.6.5 Saudi Arabia Influenza Drugs and Vaccines Consumption Forecast (2022-2028)
-
13.6.6 United Arab Emirates Influenza Drugs and Vaccines Consumption Forecast (2022-2028)
-
13.7 Africa Consumption Analysis
-
13.7.1 Nigeria Influenza Drugs and Vaccines Consumption Forecast (2022-2028)
-
13.7.2 South Africa Influenza Drugs and Vaccines Consumption Forecast (2022-2028)
-
13.7.3 Egypt Influenza Drugs and Vaccines Consumption Forecast (2022-2028)
-
13.7.4 Algeria Influenza Drugs and Vaccines Consumption Forecast (2022-2028)
-
13.8 Oceania Consumption Analysis
-
13.8.1 Australia Influenza Drugs and Vaccines Consumption Forecast (2022-2028)
-
13.8.2 New Zealand Influenza Drugs and Vaccines Consumption Forecast (2022-2028)
14 Conclusions
The List of Tables and Figures
-
Table Definition of Influenza Drugs and Vaccines
-
Figure of Influenza Drugs and Vaccines Picture
-
Table Global Influenza Drugs and Vaccines Import by Region (Top 10 Countries) (2017-2028)
-
Table Global Influenza Drugs and Vaccines Export by Region (Top 10 Countries) (2017-2028)
-
Figure Global Zanamivir Consumption and Growth Rate (2017-2022)
-
Figure Global Oseltamivir Phosphate Consumption and Growth Rate (2017-2022)
-
Figure Global Peramivir Consumption and Growth Rate (2017-2022)
-
Figure Global Trivalent Consumption and Growth Rate (2017-2022)
-
Figure Global Quadrivalent Consumption and Growth Rate (2017-2022)
-
Figure Global Hospitals Consumption and Growth Rate (2017-2022)
-
Figure Global Research Laboratories Consumption and Growth Rate (2017-2022)
-
Figure Global Pharmacies Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Influenza Drugs and Vaccines Consumption by Country (2017-2022)
-
Table North America Influenza Drugs and Vaccines Consumption by Country (2017-2022)
-
Figure United States Influenza Drugs and Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Canada Influenza Drugs and Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Mexico Influenza Drugs and Vaccines Consumption and Growth Rate (2017-2022)
-
Table Europe Influenza Drugs and Vaccines Consumption by Country (2017-2022)
-
Figure Germany Influenza Drugs and Vaccines Consumption and Growth Rate (2017-2022)
-
Figure UK Influenza Drugs and Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Spain Influenza Drugs and Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Belgium Influenza Drugs and Vaccines Consumption and Growth Rate (2017-2022)
-
Figure France Influenza Drugs and Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Italy Influenza Drugs and Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Denmark Influenza Drugs and Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Finland Influenza Drugs and Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Norway Influenza Drugs and Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Sweden Influenza Drugs and Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Poland Influenza Drugs and Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Russia Influenza Drugs and Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Turkey Influenza Drugs and Vaccines Consumption and Growth Rate (2017-2022)
-
Table APAC Influenza Drugs and Vaccines Consumption by Country (2017-2022)
-
Figure China Influenza Drugs and Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Japan Influenza Drugs and Vaccines Consumption and Growth Rate (2017-2022)
-
Figure India Influenza Drugs and Vaccines Consumption and Growth Rate (2017-2022)
-
Figure South Korea Influenza Drugs and Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Pakistan Influenza Drugs and Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Bangladesh Influenza Drugs and Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Indonesia Influenza Drugs and Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Thailand Influenza Drugs and Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Singapore Influenza Drugs and Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Malaysia Influenza Drugs and Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Philippines Influenza Drugs and Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Vietnam Influenza Drugs and Vaccines Consumption and Growth Rate (2017-2022)
-
Table South America Influenza Drugs and Vaccines Consumption by Country (2017-2022)
-
Figure Brazil Influenza Drugs and Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Colombia Influenza Drugs and Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Chile Influenza Drugs and Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Argentina Influenza Drugs and Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Venezuela Influenza Drugs and Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Peru Influenza Drugs and Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Puerto Rico Influenza Drugs and Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Ecuador Influenza Drugs and Vaccines Consumption and Growth Rate (2017-2022)
-
Table GCC Influenza Drugs and Vaccines Consumption by Country (2017-2022)
-
Figure Bahrain Influenza Drugs and Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Kuwait Influenza Drugs and Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Oman Influenza Drugs and Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Qatar Influenza Drugs and Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Saudi Arabia Influenza Drugs and Vaccines Consumption and Growth Rate (2017-2022)
-
Figure United Arab Emirates Influenza Drugs and Vaccines Consumption and Growth Rate (2017-2022)
-
Table Africa Influenza Drugs and Vaccines Consumption by Country (2017-2022)
-
Figure Nigeria Influenza Drugs and Vaccines Consumption and Growth Rate (2017-2022)
-
Figure South Africa Influenza Drugs and Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Egypt Influenza Drugs and Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Algeria Influenza Drugs and Vaccines Consumption and Growth Rate (2017-2022)
-
Table Oceania Influenza Drugs and Vaccines Consumption by Country (2017-2022)
-
Figure Australia Influenza Drugs and Vaccines Consumption and Growth Rate (2017-2022)
-
Figure New Zealand Influenza Drugs and Vaccines Consumption and Growth Rate (2017-2022)
-
Table BioCryst PharmaceuticalsInc Company Details
-
Table BioCryst PharmaceuticalsInc Influenza Drugs and Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table BioCryst PharmaceuticalsInc Influenza Drugs and Vaccines Main Business and Markets Served
-
Table BioCryst PharmaceuticalsInc Influenza Drugs and Vaccines Product Portfolio
-
Table Emergent Biosolutions Company Details
-
Table Emergent Biosolutions Influenza Drugs and Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Emergent Biosolutions Influenza Drugs and Vaccines Main Business and Markets Served
-
Table Emergent Biosolutions Influenza Drugs and Vaccines Product Portfolio
-
Table Protein Sciences Corporation Company Details
-
Table Protein Sciences Corporation Influenza Drugs and Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Protein Sciences Corporation Influenza Drugs and Vaccines Main Business and Markets Served
-
Table Protein Sciences Corporation Influenza Drugs and Vaccines Product Portfolio
-
Table Alvogen Company Details
-
Table Alvogen Influenza Drugs and Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Alvogen Influenza Drugs and Vaccines Main Business and Markets Served
-
Table Alvogen Influenza Drugs and Vaccines Product Portfolio
-
Table Sanofi Pasteur Inc Company Details
-
Table Sanofi Pasteur Inc Influenza Drugs and Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi Pasteur Inc Influenza Drugs and Vaccines Main Business and Markets Served
-
Table Sanofi Pasteur Inc Influenza Drugs and Vaccines Product Portfolio
-
Table Astrazeneca Company Details
-
Table Astrazeneca Influenza Drugs and Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Astrazeneca Influenza Drugs and Vaccines Main Business and Markets Served
-
Table Astrazeneca Influenza Drugs and Vaccines Product Portfolio
-
Table Serum Institute Of India Pvt Ltd Company Details
-
Table Serum Institute Of India Pvt Ltd Influenza Drugs and Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Serum Institute Of India Pvt Ltd Influenza Drugs and Vaccines Main Business and Markets Served
-
Table Serum Institute Of India Pvt Ltd Influenza Drugs and Vaccines Product Portfolio
-
Table Serum Institute Of India Pvt Ltd Company Details
-
Table Serum Institute Of India Pvt Ltd Influenza Drugs and Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Serum Institute Of India Pvt Ltd Influenza Drugs and Vaccines Main Business and Markets Served
-
Table Serum Institute Of India Pvt Ltd Influenza Drugs and Vaccines Product Portfolio
-
Table Emergent Biosolutions Company Details
-
Table Emergent Biosolutions Influenza Drugs and Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Emergent Biosolutions Influenza Drugs and Vaccines Main Business and Markets Served
-
Table Emergent Biosolutions Influenza Drugs and Vaccines Product Portfolio
-
Table CSL Limited Company Details
-
Table CSL Limited Influenza Drugs and Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table CSL Limited Influenza Drugs and Vaccines Main Business and Markets Served
-
Table CSL Limited Influenza Drugs and Vaccines Product Portfolio
-
Table ABPI Company Details
-
Table ABPI Influenza Drugs and Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table ABPI Influenza Drugs and Vaccines Main Business and Markets Served
-
Table ABPI Influenza Drugs and Vaccines Product Portfolio
-
Figure Global Zanamivir Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Oseltamivir Phosphate Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Peramivir Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Trivalent Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Quadrivalent Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Research Laboratories Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Influenza Drugs and Vaccines Consumption Forecast by Country (2022-2028)
-
Table North America Influenza Drugs and Vaccines Consumption Forecast by Country (2022-2028)
-
Figure United States Influenza Drugs and Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Canada Influenza Drugs and Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Mexico Influenza Drugs and Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Influenza Drugs and Vaccines Consumption Forecast by Country (2022-2028)
-
Figure Germany Influenza Drugs and Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure UK Influenza Drugs and Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Spain Influenza Drugs and Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Belgium Influenza Drugs and Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure France Influenza Drugs and Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Italy Influenza Drugs and Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Denmark Influenza Drugs and Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Finland Influenza Drugs and Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Norway Influenza Drugs and Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Sweden Influenza Drugs and Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Poland Influenza Drugs and Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Russia Influenza Drugs and Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Turkey Influenza Drugs and Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Table APAC Influenza Drugs and Vaccines Consumption Forecast by Country (2022-2028)
-
Figure China Influenza Drugs and Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Influenza Drugs and Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Influenza Drugs and Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Influenza Drugs and Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Pakistan Influenza Drugs and Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Bangladesh Influenza Drugs and Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Indonesia Influenza Drugs and Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Thailand Influenza Drugs and Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Singapore Influenza Drugs and Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Malaysia Influenza Drugs and Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Philippines Influenza Drugs and Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Vietnam Influenza Drugs and Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Table South America Influenza Drugs and Vaccines Consumption Forecast by Country (2022-2028)
-
Figure Brazil Influenza Drugs and Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Colombia Influenza Drugs and Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Chile Influenza Drugs and Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Argentina Influenza Drugs and Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Venezuela Influenza Drugs and Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Peru Influenza Drugs and Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Puerto Rico Influenza Drugs and Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Ecuador Influenza Drugs and Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Table GCC Influenza Drugs and Vaccines Consumption Forecast by Country (2022-2028)
-
Figure Bahrain Influenza Drugs and Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Kuwait Influenza Drugs and Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Oman Influenza Drugs and Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Qatar Influenza Drugs and Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Saudi Arabia Influenza Drugs and Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure United Arab Emirates Influenza Drugs and Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Table Africa Influenza Drugs and Vaccines Consumption Forecast by Country (2022-2028)
-
Figure Nigeria Influenza Drugs and Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Africa Influenza Drugs and Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Egypt Influenza Drugs and Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Algeria Influenza Drugs and Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Table Oceania Influenza Drugs and Vaccines Consumption Forecast by Country (2022-2028)
-
Figure Australia Influenza Drugs and Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure New Zealand Influenza Drugs and Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
